Presentation:
Each syringe contains 45g of oral paste containing:
Trimethoprim 5.80% w/w
Sulfadiazine 28.83% w/w
Uses:
Indicated in the treatment of bacterial infections in horses caused by sensitive microorganisms including: Escherichia coli, Rhodococcus (Corynebacterium) equi, Staphylococcus spp and Streptococcus spp.
Norodine Equine Paste may be effective in treating the following conditions. Alimentary tract infections including diarrhoea. Respiratory infections including pneumonia, pleurisy, strangles. Wounds, septicaemia and general infections.
Use of the following product should be based on susceptibility testing
Dosage & Administration:
Dosages: The daily dose is 30mg combined active ingredients per kg bodyweight. Each syringe provides one daily dose for a 500kg horse. Each division on the dial-a-dose plunger provides sufficient product to treat 50kg of bodyweight.
Treatment should be continued for up to five days or until two days after symptoms have resolved. Drug absorption may be greater if food is withheld for a few hours prior to dosing.
Administration: Adjust screw gauge on dial-a-dose plunger to the bodyweight of the horse. Remove cap from nozzle. Place nozzle in corner of mouth. Depress plunger depositing paste on upper surface of tongue. Replace cap after use.
Withdrawal Period:
Not to be used in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
Contraindictions, Warnings etc:
Do not use in cases of known hypersensitivity, severe hepatic dysfunction or cardiac arrhythmias. Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises. The product can be safely administered during pregnancy and lactation.
Take care to avoid skin and eye contact. Gloves and suitable eye protection should be worn whilst handling this product. Wash hands and exposed skin after use.
Sulphonamides may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skincontact. Hypersensitivity to sulphonamides may lead to cross reactions with other antibiotics. Allergic reactions to these substances may occasionally be serious.
1. Do not handle this product if you know you are sensitive to sulphonamides.
2. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning.
Pharmaceutical Precautions:
Do not store above 25°C. Do not freeze.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.